GSK plc (GSK.L) Earnings
Price: $1485.00
Market Cap: $60.42B
Market Cap: $60.42B
Revenue (TTM): $31.38B
Net Income: $2.58B
Net Income: $2.58B
P/E Ratio: 23.51
EPS (TTM): $0.63
EPS (TTM): $0.63
Earnings Dates
GSK plc (GSK.L) reports its earnings quarterly. Here are the key details:
Next Earnings Date
- Date: April 30, 2025
- Time of Day: Before Market Open
- Estimated EPS: $0.4326
Last Earnings Report
- Date: February 05, 2025
- EPS: $0.29
- EPS Estimate: $0.2481
GSK plc's next earnings report is scheduled for April 30, 2025.
In its last earnings report on February 05, 2025, GSK plc reported earnings per share (EPS) of $0.29, compared to an estimated EPS of $0.25. The company reported revenue of $8.12B, compared to an estimated revenue of $9.72B.
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-05 | $0.25 | $0.29 |
| Read Transcript | Q3 | 2024 | 2024-10-30 | $43.51 | $49.70 |
| Read Transcript | Q2 | 2024 | 2024-07-31 | $37.87 | $43.40 |
| Read Transcript | Q1 | 2024 | 2024-05-04 | N/A | N/A |
| Read Transcript | Q4 | 2023 | 2024-01-31 | $28.63 | $28.90 |
| Read Transcript | Q3 | 2023 | 2023-11-01 | $46.36 | $50.40 |
| Read Transcript | Q2 | 2023 | 2023-07-26 | $35.04 | $38.80 |
| Read Transcript | Q1 | 2023 | 2023-04-26 | $33.07 | $37.00 |
| Read Transcript | Q4 | 2022 | 2023-02-01 | $22.05 | $25.80 |
| Read Transcript | Q3 | 2022 | 2022-11-02 | $39.78 | $46.90 |
| Read Transcript | Q1 | 2022 | 2022-04-27 | N/A | N/A |
| Read Transcript | Q4 | 2021 | 2022-02-09 | N/A | N/A |
| Read Transcript | Q3 | 2021 | 2021-10-27 | N/A | N/A |
| Read Transcript | Q2 | 2021 | 2021-07-28 | N/A | N/A |
| Read Transcript | Q1 | 2021 | 2021-04-28 | N/A | N/A |
| Read Transcript | Q4 | 2020 | 2021-02-03 | N/A | N/A |
| Read Transcript | Q3 | 2020 | 2020-10-28 | N/A | N/A |
| Read Transcript | Q2 | 2020 | 2020-07-29 | N/A | N/A |
| Read Transcript | Q1 | 2020 | 2020-04-29 | N/A | N/A |
| Read Transcript | Q4 | 2019 | 2020-02-05 | N/A | N/A |
| Read Transcript | Q3 | 2019 | 2019-10-30 | N/A | N/A |
| Read Transcript | Q2 | 2019 | 2019-07-24 | N/A | N/A |
| Read Transcript | Q1 | 2019 | 2019-05-01 | N/A | N/A |
| Read Transcript | Q4 | 2018 | 2019-02-06 | N/A | N/A |
| Read Transcript | Q3 | 2018 | 2018-10-31 | N/A | N/A |
| Read Transcript | Q2 | 2018 | 2018-07-25 | N/A | N/A |
| Read Transcript | Q1 | 2018 | 2018-04-25 | N/A | N/A |
| Read Transcript | Q4 | 2017 | 2018-02-07 | N/A | N/A |
| Read Transcript | Q3 | 2017 | 2017-10-25 | N/A | N/A |
| Read Transcript | Q2 | 2017 | 2017-07-27 | N/A | N/A |
| Read Transcript | Q1 | 2017 | 2017-04-26 | N/A | N/A |
| Read Transcript | Q4 | 2016 | 2017-02-08 | N/A | N/A |
| Read Transcript | Q3 | 2016 | 2016-10-26 | N/A | N/A |
| Read Transcript | Q2 | 2016 | 2016-07-27 | N/A | N/A |
| Read Transcript | Q1 | 2016 | 2016-04-27 | N/A | N/A |
Earnings History
| Date | EPS | EPS Estimate | Revenue | Revenue Estimate |
|---|---|---|---|---|
| February 05, 2025 | $0.29 | $0.25 | $8.12B | $9.72B |
| October 30, 2024 | $49.70 | $43.51 | $8.01B | $10.72B |
| July 31, 2024 | $43.40 | $37.87 | $7.88B | $9.47B |
| May 01, 2024 | $43.10 | $36.42 | $7.36B | $8.94B |
| January 31, 2024 | $28.90 | $28.63 | $8.05B | $8.90B |
| November 01, 2023 | $50.40 | $46.36 | $8.15B | $8.90B |
| July 26, 2023 | $38.80 | $35.04 | $7.18B | $8.90B |
| April 26, 2023 | $37.00 | $33.07 | $6.95B | $8.90B |
| February 01, 2023 | $25.80 | $22.05 | $7.38B | $7.23B |
| November 02, 2022 | $46.90 | $39.78 | $7.83B | $7.36B |
| July 27, 2022 | $34.60 | $28.84 | $6.93B | $6.59B |
| April 27, 2022 | $40.63 | $37.70 | $9.78B | $8.96B |
| February 09, 2022 | $32.00 | $30.65 | $9.53B | $9.50B |
| October 27, 2021 | $45.75 | $36.26 | $9.08B | $- |
| July 28, 2021 | $35.13 | $25.11 | $8.09B | $- |
| April 28, 2021 | $28.63 | $26.80 | $7.42B | $- |
| February 03, 2021 | $29.13 | $29.19 | $8.74B | $- |
Annual Earnings
Annual Revenue
$31.38B
Fiscal Year 2024Annual Net Income
$2.58B
Fiscal Year 2024Annual EPS
$0.63
Fiscal Year 2024Quarterly Earnings
Revenue
$8.12B
Quarter Ending December 31, 2024Net Income
$414.00M
Quarter Ending December 31, 2024EPS
$0.10
Quarter Ending December 31, 2024Earnings Metrics
Earnings Yield
4.69%
Year Ending December 31, 2024P/E Ratio
21.32
Year Ending December 31, 2024Revenue Per Share
$7.70
Year Ending December 31, 2024Earnings Yield (TTM)
4.25%
Trailing Twelve MonthsP/E Ratio (TTM)
23.51
Trailing Twelve MonthsRevenue Per Share (TTM)
$7.70
Trailing Twelve MonthsFrequently Asked Questions
GSK plc's next earnings date is scheduled for April 30, 2025. The earnings call is expected to take place before market open.
In its last earnings report on February 05, 2025, GSK plc reported earnings per share (EPS) of $0.29, compared to an estimated EPS of $0.25. The company reported revenue of $8.12B, compared to an estimated revenue of $9.72B.
GSK plc's current Price-to-Earnings (P/E) ratio is 21.32. The trailing twelve months (TTM) P/E ratio is 23.51. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.
For the fiscal year ending December 31, 2024, GSK plc reported total revenue of $31.38B and net income of $2.58B. This represents a net profit margin of 0.0820690974.
GSK plc's earnings yield is 4.69%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.
GSK plc's return on equity (ROE) is 18.84%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.
GSK plc's gross profit margin is 71.16%. This indicates that for every dollar of revenue, the company retains $0.71 as gross profit after accounting for the cost of goods sold.
Related Metrics
Explore detailed financial metrics and analysis for GSK.L.